4,6-Dibromodibenzofuran

We are 4,6-Dibromodibenzofuran CAS:201138-91-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4,6-Dibromodibenzofuran
CAS.NO:201138-91-2
Synonyms:4,6-dibromo-dibenzofurane
Dibenzofuran,4,6-dibromo
4,6-Dibromodibenzo[b,d]furan
Molecular Formula:C12H6Br2O
Molecular Weight:325.98300
 
Physical and Chemical Properties:
Density:1.886
Boiling point:396.049ºC
Flash point:193.324ºC
 
Specification:
Appearance:Off-white powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates

4,6-Dibromodibenzofuran


Related News: In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC.4-Amino-3-chlorophenol hydrochloride CAS:52671-64-4 Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.4-Dimethylaminopyridine Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazine At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves.Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).

Related Products
Product Name
2-butyne-1,4-diol Cas:110-65-6 View Details
3-hydroxybenzaldehyde View Details
Octreotide Cas:79517-01-4 View Details
Citicoline manufacturer (3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione Cas:14805-29-9 manufacturer Molybdenum hexacarbonyl Cas:13939-06-5 manufacturer 3-Acryloxypropyl Methyl Dimethoxysilane Cas:13732-00-8 manufacturer 1-BROMO-3-IODOPROPANE manufacturer